A multicentre, retrospective study assessing Low dose versus standard dose four factor prothrombin complex concentrate for factor-Xa inhibitor reversal in spontaneous and traumatic intracranial hemorrhage
Latest Information Update: 30 Apr 2021
At a glance
- Drugs Prothrombin complex concentrate (Primary)
- Indications Intracranial haemorrhages; Traumatic intracranial haemorrhage
- Focus Therapeutic Use
- 30 Apr 2021 New trial record
- 18 Apr 2021 Primary endpoint has not been met. (Hemostatic efficacy between the low and standard dose groups), as per Results published in the Pharmacotherapy
- 18 Apr 2021 Results published in the Pharmacotherapy